IDFPIsopropyl dodecylfluorophosphonate
Organophosphorus MAGL and FAAH inhibitor (IC50 0.60 to 3.0 nM for the class); it raises brain endocannabinoids in mice.
Harm-reduction warning
No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.
C₁₅H₃₂FO₂P
CAS 615250-02-7
- Family
- ECS pharmacological toolEnzyme inhibitor
- Molar mass
- 294.39 g/mol
Updated on
In plain terms
IDFP blocks both enzymes that destroy endocannabinoids at once. In mice their levels in the brain rise sharply and behaviour changes. It is a research tool in toxicology, chemically related to organophosphorus insecticides; no study in humans was found.
Receptors and activity
Target network
- Blocks or inhibits
- Binds or modulates
The lower the cited value, the closer the target sits to IDFP: one ring per factor of 100. A target with no measured value stays on the edge.
Where these targets live
Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of IDFP.
MAGLMAGL found in 5 regions of the body
Map sources
- Takahata K et al. First-in-human in vivo imaging and quantification of monoacylglycerol lipase in the brain: a PET study with (18)F-T-401. Eur J Nucl Med Mol Imaging, 2022 (new tab)
- Ludányi A et al. Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus. Neuroscience, 2011 (new tab)
- Spoto B et al. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol. Biochimie, 2006 (new tab)
- Human Protein Atlas. MGLL expression summary (new tab)
Cited values
- MAGLInhibitorno measured value cited
IC50 of 0.60 to 3.0 nM in vitro for three O-alkyl alkylphosphonofluoridates (C1, C2, C3; C8, C12 chains), the class to which IDFP (O-isopropyl, C12) belongs; the value specific to IDFP is not isolated in the abstract (Quistad et al. 2006); more than ten-fold elevation of brain 2-AG in the mouse (Nomura et al. 2008)
- FAAHInhibitorno measured value cited
IC50 of 0.60 to 3.0 nM in vitro for the same class (Quistad et al. 2006); more than ten-fold elevation of brain anandamide in the mouse (Nomura et al. 2008); the value specific to IDFP is not isolated in the abstract
- CB1 (nucleophilic site)Binding (function not established)no measured value cited
Inhibits [3H]CP 55,940 binding on mouse brain membranes, IC50 of 2 to 11 nM for three compounds including IDFP; 84% inhibition of brain binding 4 h after 30 mg/kg intraperitoneally; functional effect at CB1 not established (Segall et al. 2003)
Pharmacology
Isopropyl dodecylfluorophosphonate (IDFP) entered the endocannabinoid literature through toxicology. Casida's teams first described organophosphorus compounds that bind CB1 (Segall et al. 2003), then showed that alkylphosphonofluoridates inhibit MAGL and FAAH in vitro with IC50 values of 0.60 to 3.0 nM, with low selectivity (Quistad et al. 2006). In mice, dual blockade of the two enzymes by selected organophosphorus agents raises brain 2-AG and anandamide more than ten-fold and produces CB1-dependent behavioural effects that resemble those of CB1 agonists (Nomura et al. 2008). Several studies have used it as a way of raising endocannabinoid signalling: acute administration raised plasma triglycerides 2.0- to 3.1-fold in mice, an effect absent in CB1-null mice and prevented by CB1 antagonists (Ruby et al. 2008), and a single dose raised hepatic triglycerides and induced insulin resistance, partly through CB1 (Ruby et al. 2011). Suzuki and colleagues used it as a comparator for the insecticide fenitrothion: IDFP raised plasma triglycerides 4.8-fold, an effect prevented by the antagonist AM251, with no notable effect on brain acetylcholinesterase (Suzuki et al. 2014). These results are preclinical; Segall and colleagues also report delayed toxicity (mortality in 0.3 to 5 days) for this compound and two others, more closely linked to inhibition of neuropathy target esterase-lysophospholipase than to that of CB1 or acetylcholinesterase. No study in humans was found.
Key sources.
- Segall Y et al. Toxicological and structural features of organophosphorus and organosulfur cannabinoid CB1 receptor ligands. Toxicol Sci, 2003 (new tab)PMID 12944586
- Quistad GB et al. Monoacylglycerol lipase inhibition by organophosphorus compounds leads to elevation of brain 2-arachidonoylglycerol and the associated hypomotility in mice. Toxicol Appl Pharmacol, 2006 (new tab)PMID 16310817
- Nomura DK et al. Activation of the endocannabinoid system by organophosphorus nerve agents. Nat Chem Biol, 2008 (new tab)PMID 18438404
- Casida JE et al. Organophosphate-sensitive lipases modulate brain lysophospholipids, ether lipids and endocannabinoids. Chem Biol Interact, 2008 (new tab)PMID 18495101
- Ruby MA et al. Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins. Proc Natl Acad Sci U S A, 2008 (new tab)PMID 18794527
- Suzuki H et al. Organophosphate agents induce plasma hypertriglyceridemia in mouse via single or dual inhibition of the endocannabinoid hydrolyzing enzyme(s). Toxicol Lett, 2014 (new tab)PMID 24361246
- PubChem, IDFP, CID 24762154 (identifiers and properties) (new tab)
History
- Source
- An entirely synthetic compound with no natural occurrence found in the sources consulted. It is described as a research tool in toxicology and pharmacology; no human, agricultural or veterinary use was found.
Origin
Research tool
No biological pathway: IDFP is a synthetic compound of the alkylphosphonofluoridate class (organophosphorus with a fatty chain), unrelated to the plant cannabinoid pathway.
Legal framework
- European Union
The substance is not listed in the Annex to Council Framework Decision 2004/757/JHA (consolidated version of 12 January 2026), which lists the new psychoactive substances controlled at European Union level; control is a matter for national law. It is not listed in the schedules of the 1971 Convention on Psychotropic Substances (INCB Green List, 36th edition, 2025, text reviewed). No marketing authorisation was found.
- France
Not classified: IDFP is not on the ANSM consolidated list of narcotics (updated 16/02/2026) and this alkylphosphonofluoridate falls within none of the generic families of that list. Its status under other regimes (organophosphorus, toxic chemicals) was not verified here.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Classification
Family, origin and source verification
- Family
ECS pharmacological tool › Enzyme inhibitor
- Verification
Classification, sources and binding values checked on 20 October 2026; text read against its sources and Wikipedia.
- Wikipedia (English)
Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.
References
- Segall Y et al. Toxicological and structural features of organophosphorus and organosulfur cannabinoid CB1 receptor ligands. Toxicol Sci, 2003 (new tab)PMID 12944586
- Quistad GB et al. Monoacylglycerol lipase inhibition by organophosphorus compounds leads to elevation of brain 2-arachidonoylglycerol and the associated hypomotility in mice. Toxicol Appl Pharmacol, 2006 (new tab)PMID 16310817
- Nomura DK et al. Activation of the endocannabinoid system by organophosphorus nerve agents. Nat Chem Biol, 2008 (new tab)PMID 18438404
- Casida JE et al. Organophosphate-sensitive lipases modulate brain lysophospholipids, ether lipids and endocannabinoids. Chem Biol Interact, 2008 (new tab)PMID 18495101
- Ruby MA et al. Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins. Proc Natl Acad Sci U S A, 2008 (new tab)PMID 18794527
- Suzuki H et al. Organophosphate agents induce plasma hypertriglyceridemia in mouse via single or dual inhibition of the endocannabinoid hydrolyzing enzyme(s). Toxicol Lett, 2014 (new tab)PMID 24361246
- PubChem, IDFP, CID 24762154 (identifiers and properties) (new tab)
Identifiers
Names
- Common name
- Isopropyl dodecylfluorophosphonate
- IUPAC name
- 1-[fluoro(propan-2-yloxy)phosphoryl]dodecane
- Other names
- IDFP
Identifiers
- Formula
- C₁₅H₃₂FO₂P
- CAS
- 615250-02-7
- PubChem CID
- 24762154(new tab)
- InChIKey
- SFRALHFBKRAJPW-UHFFFAOYSA-N
- SMILES
- CCCCCCCCCCCCP(=
O) (OC(C) C) F
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.